| pubmed-article:21384537 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21384537 | lifeskim:mentions | umls-concept:C0027651 | lld:lifeskim |
| pubmed-article:21384537 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:21384537 | lifeskim:mentions | umls-concept:C0015576 | lld:lifeskim |
| pubmed-article:21384537 | lifeskim:mentions | umls-concept:C0205653 | lld:lifeskim |
| pubmed-article:21384537 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:21384537 | lifeskim:mentions | umls-concept:C0553580 | lld:lifeskim |
| pubmed-article:21384537 | lifeskim:mentions | umls-concept:C0379582 | lld:lifeskim |
| pubmed-article:21384537 | lifeskim:mentions | umls-concept:C0205349 | lld:lifeskim |
| pubmed-article:21384537 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:21384537 | pubmed:dateCreated | 2011-5-10 | lld:pubmed |
| pubmed-article:21384537 | pubmed:abstractText | Reported overall survival (OS) rates of patients with localized Ewing sarcoma family of tumors (ESFT) are >80% when treated with the MSKCC P6 protocol. However, it has been associated with a 5.8% incidence of secondary leukemias. A modified P6 (mP6) protocol with reduced exposure to chemotherapy is presented. | lld:pubmed |
| pubmed-article:21384537 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21384537 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21384537 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21384537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21384537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21384537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21384537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21384537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21384537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21384537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21384537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21384537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21384537 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21384537 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:21384537 | pubmed:issn | 1545-5017 | lld:pubmed |
| pubmed-article:21384537 | pubmed:author | pubmed-author:MoraJaumeJ | lld:pubmed |
| pubmed-article:21384537 | pubmed:author | pubmed-author:de... | lld:pubmed |
| pubmed-article:21384537 | pubmed:author | pubmed-author:PararedaAndre... | lld:pubmed |
| pubmed-article:21384537 | pubmed:author | pubmed-author:CruzOfeliaO | lld:pubmed |
| pubmed-article:21384537 | pubmed:author | pubmed-author:RodríguezEvaE | lld:pubmed |
| pubmed-article:21384537 | pubmed:author | pubmed-author:HuguetRamonR | lld:pubmed |
| pubmed-article:21384537 | pubmed:author | pubmed-author:SuñolMarionaM | lld:pubmed |
| pubmed-article:21384537 | pubmed:author | pubmed-author:CardesaTeresa... | lld:pubmed |
| pubmed-article:21384537 | pubmed:author | pubmed-author:GalvánPatrici... | lld:pubmed |
| pubmed-article:21384537 | pubmed:author | pubmed-author:TornerFerranF | lld:pubmed |
| pubmed-article:21384537 | pubmed:author | pubmed-author:SalvadorHécto... | lld:pubmed |
| pubmed-article:21384537 | pubmed:copyrightInfo | Copyright © 2011 Wiley-Liss, Inc. | lld:pubmed |
| pubmed-article:21384537 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21384537 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:21384537 | pubmed:volume | 57 | lld:pubmed |
| pubmed-article:21384537 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21384537 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21384537 | pubmed:pagination | 69-75 | lld:pubmed |
| pubmed-article:21384537 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:21384537 | pubmed:meshHeading | pubmed-meshheading:21384537... | lld:pubmed |
| pubmed-article:21384537 | pubmed:meshHeading | pubmed-meshheading:21384537... | lld:pubmed |
| pubmed-article:21384537 | pubmed:meshHeading | pubmed-meshheading:21384537... | lld:pubmed |
| pubmed-article:21384537 | pubmed:meshHeading | pubmed-meshheading:21384537... | lld:pubmed |
| pubmed-article:21384537 | pubmed:meshHeading | pubmed-meshheading:21384537... | lld:pubmed |
| pubmed-article:21384537 | pubmed:meshHeading | pubmed-meshheading:21384537... | lld:pubmed |
| pubmed-article:21384537 | pubmed:meshHeading | pubmed-meshheading:21384537... | lld:pubmed |
| pubmed-article:21384537 | pubmed:meshHeading | pubmed-meshheading:21384537... | lld:pubmed |
| pubmed-article:21384537 | pubmed:meshHeading | pubmed-meshheading:21384537... | lld:pubmed |
| pubmed-article:21384537 | pubmed:meshHeading | pubmed-meshheading:21384537... | lld:pubmed |
| pubmed-article:21384537 | pubmed:meshHeading | pubmed-meshheading:21384537... | lld:pubmed |
| pubmed-article:21384537 | pubmed:meshHeading | pubmed-meshheading:21384537... | lld:pubmed |
| pubmed-article:21384537 | pubmed:meshHeading | pubmed-meshheading:21384537... | lld:pubmed |
| pubmed-article:21384537 | pubmed:meshHeading | pubmed-meshheading:21384537... | lld:pubmed |
| pubmed-article:21384537 | pubmed:meshHeading | pubmed-meshheading:21384537... | lld:pubmed |
| pubmed-article:21384537 | pubmed:meshHeading | pubmed-meshheading:21384537... | lld:pubmed |
| pubmed-article:21384537 | pubmed:meshHeading | pubmed-meshheading:21384537... | lld:pubmed |
| pubmed-article:21384537 | pubmed:meshHeading | pubmed-meshheading:21384537... | lld:pubmed |
| pubmed-article:21384537 | pubmed:meshHeading | pubmed-meshheading:21384537... | lld:pubmed |
| pubmed-article:21384537 | pubmed:meshHeading | pubmed-meshheading:21384537... | lld:pubmed |
| pubmed-article:21384537 | pubmed:meshHeading | pubmed-meshheading:21384537... | lld:pubmed |
| pubmed-article:21384537 | pubmed:meshHeading | pubmed-meshheading:21384537... | lld:pubmed |
| pubmed-article:21384537 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21384537 | pubmed:articleTitle | Treatment of Ewing sarcoma family of tumors with a modified P6 protocol in children and adolescents. | lld:pubmed |
| pubmed-article:21384537 | pubmed:affiliation | Department of Oncology, Hospital Sant Joan de Déu, Barcelona, Spain. jmora@hsjdbcn.org | lld:pubmed |
| pubmed-article:21384537 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21384537 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:21384537 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
